Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLU-M Tetra vs Ultrix in Volunteers Aged 60 Years and Above
NCT05308212Phase 3Completed
- Sponsor
- Saint Petersburg Scientific Research Institute of Vaccines and Serums
- Start
- Mar 2021
- Primary completion
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Flu-M in influenza, sponsored by Saint Petersburg Scientific Research Institute of Vaccines and Serums. Started Mar 2021; status: completed.
02
Drugs
Flu-M
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05308212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05308212.